Schroder Investment Management Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.8M Sell
8,580
-19,203
-69% -$6.26M ﹤0.01% 862
2025
Q1
$7.46M Buy
27,783
+4,553
+20% +$1.22M 0.01% 686
2024
Q4
$5.48M Sell
23,230
-24,112
-51% -$5.69M 0.01% 758
2024
Q3
$13M Sell
47,342
-9,382
-17% -$2.58M 0.01% 614
2024
Q2
$13.8M Sell
56,724
-32,178
-36% -$7.82M 0.02% 567
2024
Q1
$13.3M Buy
88,902
+44,427
+100% +$6.64M 0.02% 592
2023
Q4
$8.51M Buy
44,475
+36,820
+481% +$7.05M 0.01% 665
2023
Q3
$1.36M Sell
7,655
-548
-7% -$97.1K ﹤0.01% 970
2023
Q2
$1.56M Sell
8,203
-661
-7% -$126K ﹤0.01% 980
2023
Q1
$1.78M Buy
8,864
+384
+5% +$76.9K ﹤0.01% 971
2022
Q4
$2.02M Sell
8,480
-598
-7% -$142K ﹤0.01% 940
2022
Q3
$1.82M Sell
9,078
-1,745
-16% -$349K ﹤0.01% 958
2022
Q2
$1.58M Buy
10,823
+891
+9% +$130K ﹤0.01% 1009
2022
Q1
$1.64M Buy
9,932
+4,221
+74% +$697K ﹤0.01% 1043
2021
Q4
$968K Buy
5,711
+758
+15% +$128K ﹤0.01% 1039
2021
Q3
$935K Buy
4,953
+297
+6% +$56.1K ﹤0.01% 1113
2021
Q2
$789K Buy
4,656
+911
+24% +$154K ﹤0.01% 1174
2021
Q1
$529K Hold
3,745
﹤0.01% 1252
2020
Q4
$487K Hold
3,745
﹤0.01% 1202
2020
Q3
$508K Buy
3,745
+206
+6% +$27.9K ﹤0.01% 1091
2020
Q2
$524K Buy
3,539
+1,534
+77% +$227K ﹤0.01% 999
2020
Q1
$225K Buy
+2,005
New +$225K ﹤0.01% 1086
2018
Q1
Sell
-3,216
Closed -$409K 1270
2017
Q4
$409K Buy
+3,216
New +$409K ﹤0.01% 1124
2017
Q3
Sell
-22,913
Closed -$1.81M 1320
2017
Q2
$1.81M Hold
22,913
﹤0.01% 881
2017
Q1
$1.17M Buy
22,913
+9,793
+75% +$502K ﹤0.01% 930
2016
Q4
$491K Sell
13,120
-5,472
-29% -$205K ﹤0.01% 972
2016
Q3
$1.26M Hold
18,592
﹤0.01% 886
2016
Q2
$1.03M Buy
18,592
+13,042
+235% +$724K ﹤0.01% 906
2016
Q1
$328K Hold
5,550
﹤0.01% 1002
2015
Q4
$522K Hold
5,550
﹤0.01% 974
2015
Q3
$446K Hold
5,550
﹤0.01% 971
2015
Q2
$634K Sell
5,550
-6,864
-55% -$784K ﹤0.01% 958
2015
Q1
$1.29M Hold
12,414
﹤0.01% 904
2014
Q4
$1.2M Sell
12,414
-10,768
-46% -$1.04M ﹤0.01% 974
2014
Q3
$1.81M Buy
23,182
+374
+2% +$29.2K ﹤0.01% 921
2014
Q2
$1.44M Buy
22,808
+6,696
+42% +$423K ﹤0.01% 917
2014
Q1
$1.08M Sell
16,112
-5,695
-26% -$382K ﹤0.01% 961
2013
Q4
$1.4M Sell
21,807
-3,863
-15% -$248K ﹤0.01% 990
2013
Q3
$1.64M Sell
25,670
-5,225
-17% -$334K ﹤0.01% 950
2013
Q2
$958K Buy
+30,895
New +$958K ﹤0.01% 1011